245 related articles for article (PubMed ID: 29563323)
1. Endometrial Cancer Detection by DNA Methylation Analysis in Cervical Papanicolaou Brush Samples.
Wang SF; Du CY; Li M; Wen B; Shen QJ; Ma F; Zhang L; Deng H
Technol Cancer Res Treat; 2024; 23():15330338241242637. PubMed ID: 38584417
[No Abstract] [Full Text] [Related]
2. A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma.
Han C; Bellone S; Siegel ER; Altwerger G; Menderes G; Bonazzoli E; Egawa-Takata T; Pettinella F; Bianchi A; Riccio F; Zammataro L; Yadav G; Marto JA; Penet MF; Levine DA; Drapkin R; Patel A; Litkouhi B; Ratner E; Silasi DA; Huang GS; Azodi M; Schwartz PE; Santin AD
Gynecol Oncol; 2018 Jun; 149(3):585-591. PubMed ID: 29572027
[TBL] [Abstract][Full Text] [Related]
3. ctDNA Analysis for Cancer? Not So Fast.
Cancer Discov; 2018 May; 8(5):526. PubMed ID: 29572234
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy by NGS: differential presence of exons (DPE) in cell-free DNA reveals different patterns in metastatic and nonmetastatic colorectal cancer.
Olmedillas-López S; García-Olmo DC; García-Arranz M; Peiró-Pastor R; Aguado B; García-Olmo D
Cancer Med; 2018 May; 7(5):1706-1716. PubMed ID: 29573240
[TBL] [Abstract][Full Text] [Related]
5. Impact of BRCA mutations on outcomes among patients with serous endometrial cancer.
Kadan Y; Raviv O; Segev Y; Lavie O; Bruchim I; Fishman A; Michaelson R; Beller U; Helpman L
Int J Gynaecol Obstet; 2018 Jul; 142(1):91-96. PubMed ID: 29572834
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor DNA and liquid biopsy: opportunities, challenges, and recent advances in detection technologies.
Gorgannezhad L; Umer M; Islam MN; Nguyen NT; Shiddiky MJA
Lab Chip; 2018 Apr; 18(8):1174-1196. PubMed ID: 29569666
[TBL] [Abstract][Full Text] [Related]
7. Precancerous neoplastic cells can move through the pancreatic ductal system.
Makohon-Moore AP; Matsukuma K; Zhang M; Reiter JG; Gerold JM; Jiao Y; Sikkema L; Attiyeh MA; Yachida S; Sandone C; Hruban RH; Klimstra DS; Papadopoulos N; Nowak MA; Kinzler KW; Vogelstein B; Iacobuzio-Donahue CA
Nature; 2018 Sep; 561(7722):201-205. PubMed ID: 30177826
[TBL] [Abstract][Full Text] [Related]
8. Analysis of circulating tumor DNA in breast cancer as a diagnostic and prognostic biomarker.
Rohanizadegan M
Cancer Genet; 2018 Dec; 228-229():159-168. PubMed ID: 29572011
[TBL] [Abstract][Full Text] [Related]
9. Comparison of five cell-free DNA isolation methods to detect the EGFR T790M mutation in plasma samples of patients with lung cancer.
Solassol J; Quantin X; Larrieux M; Senal R; Audran P; Grand D; Mangé A; Diamandis EP; Vendrell JA
Clin Chem Lab Med; 2018 Aug; 56(9):e243-e246. PubMed ID: 29626410
[No Abstract] [Full Text] [Related]
10. Circulating cell-free DNA for non-invasive cancer management.
Stewart CM; Tsui DWY
Cancer Genet; 2018 Dec; 228-229():169-179. PubMed ID: 29625863
[TBL] [Abstract][Full Text] [Related]
11. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.
Martínez-Ricarte F; Mayor R; Martínez-Sáez E; Rubio-Pérez C; Pineda E; Cordero E; Cicuéndez M; Poca MA; López-Bigas N; Ramon Y Cajal S; Vieito M; Carles J; Tabernero J; Vivancos A; Gallego S; Graus F; Sahuquillo J; Seoane J
Clin Cancer Res; 2018 Jun; 24(12):2812-2819. PubMed ID: 29615461
[No Abstract] [Full Text] [Related]
12. Clinical Utility of Cell-Free DNA for the Detection of
McCoach CE; Blakely CM; Banks KC; Levy B; Chue BM; Raymond VM; Le AT; Lee CE; Diaz J; Waqar SN; Purcell WT; Aisner DL; Davies KD; Lanman RB; Shaw AT; Doebele RC
Clin Cancer Res; 2018 Jun; 24(12):2758-2770. PubMed ID: 29599410
[No Abstract] [Full Text] [Related]
13. Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.
Springer SU; Chen CH; Rodriguez Pena MDC; Li L; Douville C; Wang Y; Cohen JD; Taheri D; Silliman N; Schaefer J; Ptak J; Dobbyn L; Papoli M; Kinde I; Afsari B; Tregnago AC; Bezerra SM; VandenBussche C; Fujita K; Ertoy D; Cunha IW; Yu L; Bivalacqua TJ; Grollman AP; Diaz LA; Karchin R; Danilova L; Huang CY; Shun CT; Turesky RJ; Yun BH; Rosenquist TA; Pu YS; Hruban RH; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Dickman KG; Netto GJ
Elife; 2018 Nov; 7():. PubMed ID: 30418154
[No Abstract] [Full Text] [Related]
14. Minimal functional driver gene heterogeneity among untreated metastases.
Reiter JG; Makohon-Moore AP; Gerold JM; Heyde A; Attiyeh MA; Kohutek ZA; Tokheim CJ; Brown A; DeBlasio RM; Niyazov J; Zucker A; Karchin R; Kinzler KW; Iacobuzio-Donahue CA; Vogelstein B; Nowak MA
Science; 2018 Sep; 361(6406):1033-1037. PubMed ID: 30190408
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive detection of human cardiomyocyte death using methylation patterns of circulating DNA.
Zemmour H; Planer D; Magenheim J; Moss J; Neiman D; Gilon D; Korach A; Glaser B; Shemer R; Landesberg G; Dor Y
Nat Commun; 2018 Apr; 9(1):1443. PubMed ID: 29691397
[TBL] [Abstract][Full Text] [Related]
16. Targeted methylation sequencing of plasma cell-free DNA for cancer detection and classification.
Liu L; Toung JM; Jassowicz AF; Vijayaraghavan R; Kang H; Zhang R; Kruglyak KM; Huang HJ; Hinoue T; Shen H; Salathia NS; Hong DS; Naing A; Subbiah V; Piha-Paul SA; Bibikova M; Granger G; Barnes B; Shen R; Gutekunst K; Fu S; Tsimberidou AM; Lu C; Eng C; Moulder SL; Kopetz ES; Amaria RN; Meric-Bernstam F; Laird PW; Fan JB; Janku F
Ann Oncol; 2018 Jun; 29(6):1445-1453. PubMed ID: 29635542
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of liquid from the Papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers.
Wang Y; Li L; Douville C; Cohen JD; Yen TT; Kinde I; Sundfelt K; Kjær SK; Hruban RH; Shih IM; Wang TL; Kurman RJ; Springer S; Ptak J; Popoli M; Schaefer J; Silliman N; Dobbyn L; Tanner EJ; Angarita A; Lycke M; Jochumsen K; Afsari B; Danilova L; Levine DA; Jardon K; Zeng X; Arseneau J; Fu L; Diaz LA; Karchin R; Tomasetti C; Kinzler KW; Vogelstein B; Fader AN; Gilbert L; Papadopoulos N
Sci Transl Med; 2018 Mar; 10(433):. PubMed ID: 29563323
[TBL] [Abstract][Full Text] [Related]
18. Correlation between circulating cell-free PIK3CA tumor DNA levels and treatment response in patients with PIK3CA-mutated metastatic breast cancer.
Kodahl AR; Ehmsen S; Pallisgaard N; Jylling AMB; Jensen JD; Laenkholm AV; Knoop AS; Ditzel HJ
Mol Oncol; 2018 Jun; 12(6):925-935. PubMed ID: 29689598
[TBL] [Abstract][Full Text] [Related]
19. Repurposing Pan-HDAC Inhibitors for ARID1A-Mutated Ovarian Cancer.
Fukumoto T; Park PH; Wu S; Fatkhutdinov N; Karakashev S; Nacarelli T; Kossenkov AV; Speicher DW; Jean S; Zhang L; Wang TL; Shih IM; Conejo-Garcia JR; Bitler BG; Zhang R
Cell Rep; 2018 Mar; 22(13):3393-3400. PubMed ID: 29590609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
